• Clover Health Investments (NASDAQ:CLOV) is down 13% in after-hours trading Wednesday after releasing Q3 results that missed on the top line. The bottom line was a beat.
• The health insurer also boosted its full-year guidance midpoint to target an updated range of adjusted EBITDA profitability of $55M-$65M.
• In the quarter, the company's net loss narrowed to ~$9.2M compared to ~$41.5M in the year-ago period.
• Clover Health ended the quarter with restricted and unrestricted cash, cash equivalents, and investments of $531.4M, a 20.9% decline from the end of Q3 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.